Cirrhotic cardiomyopathy: an endocannabinoid connection?
- 1 October 2005
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 146 (3) , 313-314
- https://doi.org/10.1038/sj.bjp.0706332
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptorsGut, 2005
- Blood pressure regulation by endocannabinoids and their receptorsNeuropharmacology, 2005
- Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in HypertensionCirculation, 2004
- Lipopolysaccharide Induces Anandamide Synthesis in Macrophages via CD14/MAPK/Phosphoinositide 3-Kinase/NF-κB Independently of Platelet-activating FactorJournal of Biological Chemistry, 2003
- Cannabinoids Acting on CB1 Receptors Decrease Contractile Performance in Human Atrial MuscleJournal of Cardiovascular Pharmacology, 2003
- Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the ratGastroenterology, 2002
- Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver diseaseHeart, 2002
- Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosisNature Medicine, 2001
- Biosynthesis and inactivation of the endocannabinoid 2‐arachidonoylglycerol in circulating and tumoral macrophagesEuropean Journal of Biochemistry, 1999
- Cirrhotic Cardiomyopathy: Getting to the Heart of the MatterHepatology, 1996